Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... a hypoglycemic attack, as swift action to administer oral carbohydrate or injectable glucagon can quickly resolve a hypoglycemic episode, before requiring paramedic help or hospital ...
2009 NOV 23 ... resistant starch in the large intestine turns on the genes that make satiety hormones glucagon-like peptide-1 (GLP-1) and peptide YY (PYY), and that these hormones remained elevated ...
2009 NOV 23 ... a hypoglycemic attack, as swift action to administer oral carbohydrate or injectable glucagon can quickly resolve a hypoglycemic episode, before requiring paramedic help or hospital ...
2009 NOV 16 ... migratory erythema (NME), low aminoacidemia, and a marked increase of the serum glucagon level (4,940 pg/ml)," investigators in Kawasaki, Japan report. "Thus, we ...
2009 NOV 23 ... that ablation of beta-cells resulted in a reduction of not only beta-cells but also glucagon-producing alpha-cells; in contrast, delta-cells were largely unaffected. Ablation of ...
2009 NOV 16 ... In the last few years, research regarding gut hormones, such as peptide YY (PYY) and glucagon-like peptide (GLP-1), has shown that their release after a meal acts on the brain and ...
2009 NOV 23 ... 2 diabetes mellitus (T2DM), is an albumin-fusion peptide. The compound is a mimetic of glucagon-like peptide 1 (GLP-1), a hormone that decreases glucose levels, but has a short ...
2009 NOV 23 ... through its direct insulinotropic action on beta-cells and through FA stimulation of glucagon-like peptide 1 (GLP-1) secretion. GPR120 is expressed in L-cells and was also shown to ...
2009 NOV 16 ... from the United States, "We report the efficacy of a new peptide with agonism at the glucagon and GLP-1 receptors that has potent, sustained satiation-inducing and lipolytic effects. ...
2009 NOV 23 ... involved, cAMP is particularly important for amplifying insulin secretion. Recently, glucagon-like peptide-1 (GLP-1) analogues and dipeptidyl peptidase-IV (DPP-IV) inhibitors have ...
2009 NOV 23 ... insulin level (r = 0.592 P = .002) at 1 month after surgery. Furthermore, plasma glucagon-like peptide-1 and serum high-molecular weight adiponectin levels increased in both ...
2009 NOV 16 ... inhibition of DPP-4 by linagliptin was also demonstrated in vivo, resulting in increased glucagon-like peptide 1 levels and improved glucose tolerance in both healthy animals and models ...
2009 NOV 23 ... on simple or double staining with antibodies raised against: DOG1, insulin, glucagon, somatostatin, NK1, PGP9.5, chromogranin A, and synaptophysin. All the tested GISTs were ...
2009 NOV 23 ... intestine results in increased secretion and concomitant glucose-lowering effects of glucagon-like peptide-1, whereas the 'foregut hypothesis' emphasises that surgical bypass of ...
2009 NOV 10 ... in the United States report. "Insulin signaling acts together with the glucagon-stimulated cAMP signaling pathway to orchestrate the organism response to various ...
2009 NOV 23 ... inhibitors generally are weight-neutral in addition to lowering glucose, while the glucagon-like peptide-1 receptor agonists lead to weight reduction. with type 2 diabetes are at ...
2009 NOV 23 ... are weight-neutral or weight-sparing. The incretin-based therapies, such as the glucagon-like peptide-1 (GLP-1) receptor agonists and the dipeptidyl peptidase-4 inhibitors, have ...
2009 NOV 9 ... "The aim of this study was to investigate the mechanisms involved in the effect of glucagon-like peptide-1 (GLP-1) on the decrease in gastric mucosal blood flow (GMBF) induced by ...
